from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2270/lppN

LFCtreatmentdescriptionclass of inhibitor

-0.210

Amikacinug/mL Amikacintranslation

-0.302

Cap5-10ug/mL Capreomycintranslation

-0.373

Rox10-50 ug/mL Roxithromycintranslation

-0.334

SM2-5 ug/mL Streptomycintranslation

-0.945

Tet5-10 ug/mL Tetracyclinetranslation

1.974

Rif0.2-5ug/mL Rifampicintranscription

0.653

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.248

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.214

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.145

CPZ10-50 ug/mL Chlorpromazinerespiration

0.833

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.208

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.037

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.667

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.933

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.029

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.164

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.592

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.108

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.347

KCN5-20 ug/mL Potassium cyaniderespiration

-0.153

NaN30.2-2 mM Sodium aziderespiration

-1.556

Nigericin50 uM Nigericinrespiration

0.754

TRC10-150 ug/mL Triclosanrespiration

1.350

TRZ10-25 ug/mL Thioridazinerespiration

0.491

Valinomycin0.5-10 uM Valinomycinrespiration

-1.946

ZnSO42 mM ZnSO4respiration

-0.035

menadione6-10 ug/mL Menadionerespiration

-0.217

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.758

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.194

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.985

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.999

NRP_1Non-replicating persistence stage 1dosRassociated

0.168

Amp0.2mg/mL AmpicillincellWall

-0.141

Cephalexin20-100 ug/mL CephalexincellWall

-0.710

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.187

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.467

EMB10-20 ug/mL EthambutolcellWall

-0.555

Eta12-40 ug/mL EthionamidecellWall

-0.796

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.025

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.571

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.294

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.423

BZA0.12 mg/mL BenzamidearomaticAmides

-0.143

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.306

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.663

H2O24 mM hydrogen peroxideDNAdamaging

0.534

Levo10 ug/mL LevofloxacinDNAdamaging

-0.627

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.011

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.034

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.046

UVUV-irradiationDNAdamaging

1.608

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.072

Antimycin12.5-50 ug/mL Antimycin A?

-0.154

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.425

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.536

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.204

PA8240.2-2 ug/mL PA-824?

0.851

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.407

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.247

Verapamil50 uM Verapamil?

0.209

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.747

methoxatin10-20 ug/mL Methoxatin?